We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IT icon
601
Gartner
IT
$11.1B
$247K 0.03%
+3,500
New +$244K
UHS icon
602
Universal Health Services
UHS
$10.2B
$247K 0.03%
2,580
– –
XLNX
603
DELISTED
Xilinx Inc
XLNX
$246K 0.02%
5,200
-100
-2% -$4.81K
EXR icon
604
Extra Space Storage
EXR
$32.3B
$245K 0.02%
+4,600
New +$237K
HIG icon
605
Hartford Financial Services
HIG
$39.9B
$243K 0.02%
6,790
-3,100
-31% -$109K
ANK
606
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
$243K 0.02%
4,188
-2,310
-36% -$134K
NWL icon
607
Newell Brands
NWL
$2.21B
$242K 0.02%
7,820
– –
AA icon
608
Alcoa
AA
$11.3B
$241K 0.02%
6,742
-2,621
-28% -$85.9K
NSR
609
DELISTED
Neustar Inc
NSR
$241K 0.02%
+9,270
New +$252K
ZBH icon
610
Zimmer Biomet
ZBH
$18.8B
$240K 0.02%
2,379
-2,266
-49% -$221K
FLS icon
611
Flowserve
FLS
$8.94B
$239K 0.02%
3,220
-100
-3% -$7.58K
RHI icon
612
Robert Half
RHI
$4.11B
$239K 0.02%
+5,010
New +$224K
FITB
613
Fifth Third Bancorp
FITB
$51.3B
$237K 0.02%
11,100
-9,300
-46% -$197K
CEMP
614
DELISTED
Cempra, Inc.
CEMP
$236K 0.02%
21,951
-15,000
-41% -$145K
DLX icon
615
Deluxe
DLX
$1.25B
$235K 0.02%
4,015
-470
-10% -$25.7K
ALL icon
616
Allstate
ALL
$70.6B
$234K 0.02%
3,980
-4,500
-53% -$259K
MTD icon
617
Mettler-Toledo International
MTD
$28.1B
$233K 0.02%
920
– –
WSM icon
618
Williams-Sonoma
WSM
$27.5B
$233K 0.02%
+6,480
New +$213K
FIS icon
619
Fidelity National Information Services
FIS
$24.2B
$232K 0.02%
4,243
-3,300
-44% -$177K
BSX icon
620
Boston Scientific
BSX
$68.4B
$231K 0.02%
18,100
-13,500
-43% -$176K
RJET
621
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
$230K 0.02%
21,197
– –
QCOR
622
DELISTED
QUESTCOR PHARMA INC
QCOR
$230K 0.02%
2,492
-2,577
-51% -$221K
PPO
623
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$228K 0.02%
+4,770
New +$195K
ETR icon
624
Entergy
ETR
$50.3B
$227K 0.02%
+5,540
New +$207K
VSAT icon
625
Viasat
VSAT
$9.67B
$226K 0.02%
3,892
– –
23 24
25
26 27

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.